| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $26,755 ) |
| | 2025 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01AG075532 | Contribution of vestibular dysfunction and its central multisensory integration to imbalance in aging | 000 | 1 | NIH | 10/17/2024 | $0 |
| | 2025 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY035717 | Finding Missing Genetic Causality of Inherited Retinal Degenerations | 000 | 1 | NIH | 10/10/2024 | $0 |
| | 2025 | 2023 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U24DC013983 | NIDCD National Temporal Bone Hearing and Balance Pathology Resource Registry | 000 | 10 | NIH | 11/14/2024 | $0 |
| | 2025 | 2023 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01CA260857 | Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy | 001 | 4 | NIH | 10/22/2024 | $26,755 |
|
| Issue Date FY: 2024 ( Subtotal = $36,977,997 ) (Continued on the next page) |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01AG073161 | Novel Neuromodulation Treatment of Age Related Vestibular Loss to Improve Balance and Gait in Elderly Individuals | 002 | 4 | NIH | 9/3/2024 | $537,052 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K23EY035342 | Genetics of central serous chorioretinopathy and choroidal thickening | 000 | 1 | NIH | 4/22/2024 | $277,050 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U01DP006822 | DP24-081 The Glaucoma and Retinopathy Screening Study | 00 | 1 | CDC | 8/12/2024 | $720,000 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U01DP006822 | DP24-081 The Glaucoma and Retinopathy Screening Study | 00 | 1 | CDC | 8/12/2024 | $30,000 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DE033427 | Fluorescence lifetime-based tumor contrast enhancement using exogenous probes | 003 | 3 | NIH | 9/19/2024 | $456,031 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | P30EY014104 | P30 Core Grant for Vision Research | 000 | 21 | NIH | 9/3/2024 | $670,796 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY036444 | Point-of-Care Metagenomics for Rapid Detection of pathogens and Antimicrobial Resistance in Sight-Threatening Ocular Infections | 000 | 1 | NIH | 7/29/2024 | $425,000 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01CA260857 | Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy | 002 | 5 | NIH | 6/12/2024 | $436,422 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC017078 | Corticofugal Circuits for Active Listening | 000 | 8 | NIH | 7/3/2024 | $703,354 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R00EY032110 | Elucidating the molecular and cellular mechanisms underlying cone survival in the peripheral retina in mouse models of Retinitis Pigmentosa | 000 | 4 | NIH | 6/28/2024 | $249,000 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC021606 | Improving Cochlear Implant Outcomes Through Modeling and Programming Strategies Based on Human Inner Ear Pathology | 000 | 2 | NIH | 7/18/2024 | $489,110 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K08EY031759 | The Fibrosis-Immunity Interface in Corneal Transplantation | 000 | 5 | NIH | 7/12/2024 | $238,682 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY030973 | Neurophysiological Correlates of Visual Motion Processing in Cerebral Visual Impairment | 001 | 5 | NIH | 7/18/2024 | $255,388 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY012910 | Precision Medicine for Inherited Retinal Degenerations | 002 | 27 | NIH | 7/19/2024 | $640,774 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | P50DC015857 | Cochlear Synaptopathy: Prevalence, Diagnosis and Functional Consequences | 000 | 8 | NIH | 7/31/2024 | $2,684,343 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY036518 | Enhancing Glaucoma Risk Prediction through Advanced Genomics and Machine Learning | 000 | 1 | NIH | 8/2/2024 | $715,098 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | P50DC019900 | Next-generation clinical phenotyping and pathophysiology of laryngeal dystonia and voice tremor | 001 | 4 | NIH | 8/3/2024 | $2,358,689 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC021439 | Development and Plasticity of Neural Circuits Underlying Sound Encoding | 000 | 1 | NIH | 7/25/2024 | $599,219 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R13EY036277 | Advancing Eye Health through Data Science and Artificial Intelligence | 000 | 1 | NIH | 7/26/2024 | $35,070 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R00EY032110 | Elucidating the molecular and cellular mechanisms underlying cone survival in the peripheral retina in mouse models of Retinitis Pigmentosa | 001 | 4 | NIH | 7/1/2024 | $135,755 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | T32DC000020 | Research Training in Otolaryngology | 000 | 32 | NIH | 7/24/2024 | $173,089 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY031820 | Defining early-onset glaucomagenetic etiologies | 000 | 5 | NIH | 7/15/2024 | $729,244 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC020322 | Determination of Hair Cell Fate from Postnatal Cochlear Supporting Cells | 000 | 3 | NIH | 4/18/2024 | $617,363 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC009836 | Activity-Dependent Influences on Auditory Circuits | 000 | 15 | NIH | 3/26/2024 | $601,314 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY036137 | Rapid Diagnosis of Ocular Infections using a Sensitive and Highly Multiplexed Broad Pathogen Detection Assay | 000 | 1 | NIH | 4/11/2024 | $425,000 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC013303 | Human Cochlear Structure & Function | 001 | 10 | NIH | 5/2/2024 | $49,162 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | P01AI083214 | Harvard-wide Program on Antibiotic Resistance | 003 | 16 | NIH | 4/24/2024 | $227,172 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY019703 | Cell Biology of Astrocyte-Ganglion Cell Interactions in the Retina and Optic Nerve | 001 | 14 | NIH | 4/4/2024 | $425,000 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY033107 | CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases | 000 | 3 | NIH | 5/2/2024 | $595,058 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY020902 | The Pathogenesis of RNA Splicing Factor Associated Retinal Degeneration | 000 | 13 | NIH | 3/20/2024 | $645,705 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R13DC013748 | International Hearing Aid Conference (IHCON) 2024 | 000 | 8 | NIH | 1/29/2024 | $60,000 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K08DC018575 | Mechanisms of Conductive Presbycusis in Humans | 000 | 5 | NIH | 3/19/2024 | $190,080 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC013303 | Human Cochlear Structure & Function | 000 | 10 | NIH | 2/21/2024 | $442,452 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY030088 | Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration | 000 | 5 | NIH | 2/21/2024 | $419,891 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | P01AI083214 | Harvard-wide Program on Antibiotic Resistance | 002 | 16 | NIH | 1/22/2024 | $2,044,573 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY031291 | Regulation of the neuroinflammatory response in autoimmune uveitis | 000 | 4 | NIH | 11/29/2023 | $425,000 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K00EY037098 | Dual CRISPR/Cas9 exon deleting approach for the treatment of USH2A-associated disorders | 000 | 3 | NIH | 6/25/2024 | $88,560 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC000188 | Cochlear synaptopathy in noise-induced and age-related hearing loss: mechanisms and treatments | 002 | 43 | NIH | 2/21/2024 | $621,200 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY020928 | Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma | 000 | 12 | NIH | 7/15/2024 | $496,614 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC000188 | Cochlear synaptopathy in noise-induced and age-related hearing loss: mechanisms and treatments | 003 | 43 | NIH | 5/2/2024 | $69,022 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC019353 | Adaptive closed-loop brain-computer interface therapeutic intervention in laryngeal dystonia | 000 | 4 | NIH | 8/1/2024 | $361,250 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY035717 | Finding Missing Genetic Causality of Inherited Retinal Degenerations | 000 | 1 | NIH | 9/9/2024 | $684,891 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC011805 | Imaging genetics of laryngeal dystonia | 000 | 14 | NIH | 7/17/2024 | $1 |
| | 2024 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY022305 | NEIGHBORHOOD Consortium for POAG Genetics | 001 | 12 | NIH | 1/30/2024 | $565,003 |
|
